Clinical significance of clusterin expression in pancreatic adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestat...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/146 |
_version_ | 1818524518043353088 |
---|---|
author | Jin Junshuo Kim Joon-Mee Hur Yoon-Seok Cho Won Lee Keon-Young Ahn Seung-Ik Hong Kee Park In-Sun |
author_facet | Jin Junshuo Kim Joon-Mee Hur Yoon-Seok Cho Won Lee Keon-Young Ahn Seung-Ik Hong Kee Park In-Sun |
author_sort | Jin Junshuo |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestation of clusterin and clinicopathologic parameters in pancreas cancer patients. In the present study, the authors investigated the expression of clusterin and its clinical significance in pancreatic adenocarcinoma.</p> <p>Methods</p> <p>Immunohistochemical staining was performed for clusterin in tumor tissues obtained from patients who received pancreatic resection with radical intent, and the associations of clusterin expression with various clinicopathologic parameters were analyzed in addition to the relation between its expression and survival.</p> <p>Results</p> <p>Immunoreactivity for clusterin was observed in 17 of the 52 (33%) pancreatic adenocarcinomas examined. In addition, clusterin positivity was found to be associated with preoperative serum carcinoembryonic antigen level, perineural invasion, and, most strongly, lymph node metastasis. The survival analysis identified tumor differentiation and lymph node metastasis as the only significant prognostic factors.</p> <p>Conclusion</p> <p>Although not an independent prognostic factor, clusterin immunoreactivity can be used in conjunction with lymph node metastasis to predict survival in cases of pancreatic adenocarcinoma.</p> |
first_indexed | 2024-12-11T05:58:07Z |
format | Article |
id | doaj.art-3d237004a3994a3b93bd14f001631a64 |
institution | Directory Open Access Journal |
issn | 1477-7819 |
language | English |
last_indexed | 2024-12-11T05:58:07Z |
publishDate | 2012-07-01 |
publisher | BMC |
record_format | Article |
series | World Journal of Surgical Oncology |
spelling | doaj.art-3d237004a3994a3b93bd14f001631a642022-12-22T01:18:35ZengBMCWorld Journal of Surgical Oncology1477-78192012-07-0110114610.1186/1477-7819-10-146Clinical significance of clusterin expression in pancreatic adenocarcinomaJin JunshuoKim Joon-MeeHur Yoon-SeokCho WonLee Keon-YoungAhn Seung-IkHong KeePark In-Sun<p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestation of clusterin and clinicopathologic parameters in pancreas cancer patients. In the present study, the authors investigated the expression of clusterin and its clinical significance in pancreatic adenocarcinoma.</p> <p>Methods</p> <p>Immunohistochemical staining was performed for clusterin in tumor tissues obtained from patients who received pancreatic resection with radical intent, and the associations of clusterin expression with various clinicopathologic parameters were analyzed in addition to the relation between its expression and survival.</p> <p>Results</p> <p>Immunoreactivity for clusterin was observed in 17 of the 52 (33%) pancreatic adenocarcinomas examined. In addition, clusterin positivity was found to be associated with preoperative serum carcinoembryonic antigen level, perineural invasion, and, most strongly, lymph node metastasis. The survival analysis identified tumor differentiation and lymph node metastasis as the only significant prognostic factors.</p> <p>Conclusion</p> <p>Although not an independent prognostic factor, clusterin immunoreactivity can be used in conjunction with lymph node metastasis to predict survival in cases of pancreatic adenocarcinoma.</p>http://www.wjso.com/content/10/1/146PancreasAdenocarcinomaClusterinSurvival |
spellingShingle | Jin Junshuo Kim Joon-Mee Hur Yoon-Seok Cho Won Lee Keon-Young Ahn Seung-Ik Hong Kee Park In-Sun Clinical significance of clusterin expression in pancreatic adenocarcinoma World Journal of Surgical Oncology Pancreas Adenocarcinoma Clusterin Survival |
title | Clinical significance of clusterin expression in pancreatic adenocarcinoma |
title_full | Clinical significance of clusterin expression in pancreatic adenocarcinoma |
title_fullStr | Clinical significance of clusterin expression in pancreatic adenocarcinoma |
title_full_unstemmed | Clinical significance of clusterin expression in pancreatic adenocarcinoma |
title_short | Clinical significance of clusterin expression in pancreatic adenocarcinoma |
title_sort | clinical significance of clusterin expression in pancreatic adenocarcinoma |
topic | Pancreas Adenocarcinoma Clusterin Survival |
url | http://www.wjso.com/content/10/1/146 |
work_keys_str_mv | AT jinjunshuo clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT kimjoonmee clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT huryoonseok clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT chowon clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT leekeonyoung clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT ahnseungik clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT hongkee clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma AT parkinsun clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma |